Загрузка...
No Benefit of Continuing versus Stopping 5-Aminosalicylates in Patients with Ulcerative Colitis Escalated to Anti-metabolite Therapy
BACKGROUND: Whilst continuation of 5-aminosalicylates (5-ASA) after escalation to biologic therapy is considered ineffective in patients with ulcerative colitis (UC), their role in patients escalated to anti-metabolites is unclear. AIMS: We compared patterns and outcomes of continuing versus stoppin...
Сохранить в:
| Опубликовано в: : | Aliment Pharmacol Ther |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8015755/ https://ncbi.nlm.nih.gov/pubmed/32573825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.15876 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|